Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance

Cognizant's Next-Generation "Business Process as a Service" Model to Provide Lilly USA Greater Flexibility and Predictability

TEANECK, New Jersey, January 20, 2011 - Cognizant (Nasdaq: CTSH), a leading provider of consulting, technology,
and business process outsourcing (BPO) services, announced that it has been
selected by Eli Lilly and Company, one the world's leading innovation-driven
pharmaceutical companies, to deliver an end-to-end set of services to help
Lilly's U.S. sales and marketing operations be more effective, efficient, and
innovative.

Under the multiyear contract, Cognizant will deliver a tightly bundled
range of solutions spanning commercial analytics, sales force planning, sales
incentive compensation, customer relationship management, business reporting,
data warehousing, and state compliance reporting using a consumption-based
service delivery model called Business Process as a Service (BPaaS).

As part of the BPaaS model, Cognizant will combine cloud-based IT
infrastructure, Cognizant's proprietary software applications and other
intellectual property for commercial operations in life sciences, and
business process outsourcing expertise to enable Lilly to move from a
high-fixed-cost, capital-intensive model to a variable, consumption-based
cost structure, resulting in greater flexibility and predictability to meet
evolving sales and marketing needs. Cognizant's solution will enable a key
component of Lilly's transformation strategy of increased collaboration in a
globally networked model that aligns people, process and technology to drive
sales and marketing innovation.

"This expansion of our relationship with Cognizant is another step in our
mission to become the most customer-focused pharmaceutical company in the
U.S. market," said David Ricks, President, Lilly USA. "By collaborating with
the industry leader in commercial operations service delivery, we will
sharpen our own focus on understanding and exceeding our customers' needs-the
path forward to delivering business results in our increasingly challenging
environment."

"We are committed to helping Lilly USA transform its commercial
operations, providing a broad portfolio of integrated services to ensure
business agility, continuous improvement, and the most innovative approaches.
At a time of enormous regulatory and economic pressures in the life sciences
industry, our BPaaS approach will help Lilly reduce risk, have the
flexibility to rapidly scale up or down, and be highly responsive to market
demands," said Nagaraja Srivatsan, Senior Vice President and Head of Life
Sciences, North America, for Cognizant.

About Cognizant

Cognizant (Nasdaq: CTSH) is a leading provider of information technology,
consulting, and business process outsourcing services. Cognizant's
single-minded passion is to dedicate our global technology and innovation
know-how, our industry expertise and worldwide resources to working together
with clients to make their businesses stronger. With over 50 global delivery
centers and more than 100,000 employees as of December 1, 2010, we combine a
unique global delivery model infused with a distinct culture of customer
satisfaction. A member of the NASDAQ-100 Index and S&P 500 Index, Cognizant
is a Forbes Global 2000 company and a member of the Fortune 1000 and is
ranked among the top information technology companies in BusinessWeek's Hot
Growth and Top 50 Performers listings. Visit us online at
www.cognizant.com or follow us on www.twitter.com/Cognizant.

Forward-Looking Statements

This press release includes statements which may constitute
forward-looking statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995, the accuracy of which are
necessarily subject to risks, uncertainties, and assumptions as to future
events that may not prove to be accurate. Factors that could cause actual
results to differ materially from those expressed or implied include general
economic conditions and the factors discussed in our most recent Form 10-K
and other filings with the Securities and Exchange Commission. Cognizant
undertakes no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or otherwise.

Catherine Marenghi (U.S.), Public Relations, Cognizant, +1-781-223-8673, catherine.marenghi at cognizant.com; or Harsh Kabra (India), +91-982-327-3191, Harsh.Kabra at cognizant.com